Metabolite biomarkers for diagnosis and prognosis of pediatric septic shock

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8969017
APP PUB NO 20140205591A1
SERIAL NO

14160712

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for differentiating a pediatric subject with pediatric septic shock from a healthy pediatric subject or one having sudden inflammatory response syndrome (SIRS). Also provided is a method of predicting pediatric septic shock mortality in a pediatric septic shock patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UTI LIMITED PARTNERSHIPSUITE 130 3553-31 STREET N W CALGARY ALBERTA T2L 2K7

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mickiewicz, Beata Calgary, CA 1 4
Vogel, Hans J Calgary, CA 4 6
Winston, Brent W Calgary, CA 1 4
Wong, Hector R Calgary, CA 14 36

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00